We Won’t Have to Worry About Drug Shortages Ever Again… Billions Up for Grabs in 5G Build-Out… Crypto FOMO Kicks Into Overdrive Editor’s Note: You’re receiving this content as a part of your subscription to The Bleeding Edge with Jeff Brown. Below, you’ll find world-class investment research from Jeff and our rolodex of experts. We Won’t Have to Worry About Drug Shortages Ever Again One of the best ways to spot the biggest trends in tech is to keep an eye on what’s happening in the world of venture capital (VC). And right now, one biotech player fueling the U.S. manufacturing renaissance is capturing the attention of investors… Crypto FOMO Is Kicking Into Overdrive Crypto’s biggest peak is nearly upon us… and it’s not too late to ride it into overdrive. Billions of Dollars Up for Grabs in 5G Buildout While major communications companies like Verizon and AT&T make all the headlines… speculating on the small companies powering 5G can mint real fortunes… Here Come the Hacks COVID-19 has flipped the U.S. upside down. Some 20 million people are still collecting unemployment, the wealth gap grows ever wider, and the economy is sluggish. With December finally upon us, it might not be the jolly holiday season we hoped for… Precision Medicine Can Detect Cancer in Its Earliest Forms Tech expert Jeff Brown tried out an emerging approach to treat and prevent diseases. To ensure our emails continue reaching your inbox, please add our email address to your address book. This editorial email containing advertisements was sent to phanphuongthanh89.822152@blogger.com because you subscribed to this service. To stop receiving these emails, click here. Legacy Research Group welcomes your feedback and questions. But please note: The law prohibits us from giving personalized advice. To contact Customer Service, call toll free Domestic/International: 1-888-413-5232, Mon–Fri, 9am–5pm ET, or email us here. 55 NE 5th Avenue, Delray Beach, FL 33483. © 2020 Legacy Research Group, LLC. All rights reserved. Any reproduction, copying, or redistribution of our content, in whole or in part, is prohibited without written permission from Legacy Research Group, LLC. Privacy Policy | Terms of Use